Endpoints 11 2026 winner SonoThera has a new approach to non-viral gene therapy
Key leaders Kenneth Greenberg (CEO), Steve Feinstein (CSO) Headquarters San Francisco Total raised $186M Key investors Vida Ventures, ARCH Ventures Partners, Illumina Ventures, Leaps by Bayer, Johnson & Johnson Innovation, Eli Lilly ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Endpoints 11 2026 winner Azalea melds gene editing and CAR-T endpoints.news